ClinicalTrials.gov record
Withdrawn Phase 3 Interventional

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1

ClinicalTrials.gov ID: NCT05219864

Public ClinicalTrials.gov record NCT05219864. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 3:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1 (TRuE-CHE1): A Phase 3, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Open-Label Extension Period in Adults With Chronic Hand Eczema

Study identification

NCT ID
NCT05219864
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

  • Ruxolitinib cream Drug
  • Vehicle Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 30, 2023
Primary completion
Apr 24, 2024
Completion
Sep 21, 2024
Last update posted
Nov 16, 2022

2023 – 2024

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Southwest Skin Specialists Phoenix Biltmore Phoenix Arizona 85018
Raoof Md Encino Encino California 91436
First Oc Dermatology Fountain Valley California 92708
Marvel Clinical Research Llc Huntington Beach California 92647
Well Pharma Medical Research Corporation Miami Florida 33173
Psoriasis Treatment Center of South Florida Pembroke Pines Florida 33028
Lenus Research Medical Group, Llc Sweetwater Florida 33172
Delricht Research Marietta Georgia 30060
Arlington Dermatology Rolling Meadows Illinois 60008
Midwest Allergy Sinus Asthma, Sc Springfield Illinois 62604
Dermatologist Specialist Louisville Kentucky 40241
Grafton Dermatology and Cosmetic Surgery Houma Louisiana 70364
Delricht Research New Orleans Louisiana 70115
Washington University St Louis Missouri 63110
Jubilee Clinical Research Inc Las Vegas Nevada 89106
Juva Skin and Laser Center New York New York 10022
Oregon Medical Research Center Portland Oregon 97223
Oregon Health & Science University Portland Oregon 97239
Clinical Neuroscience Solutions Cns Healthcare Memphis Research Center Memphis Tennessee 38119
International Clinical Research Tennessee Llc Murfreesboro Tennessee 37130
Austin Institute For Clinical Research Aicr Pflugerville Houston Texas 77056
Progressive Clinical Research San Antonio Texas 78213
Center For Clinical Studies Webster Webster Texas 77598
University of Utah Murray Utah 84107
West End Dermatology Associates Richmond Virginia 23233
Dermatology Specialists of Spokane Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05219864, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 16, 2022 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05219864 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →